Advertisement

Molecular Diversity

, Volume 11, Issue 2, pp 107–111 | Cite as

Synthesis of C-11 modified mifepristone analog libraries

  • Gregory L. Hamilton
  • Bradley J. Backes
Short Communication

Abstract

Substitution of the C-11 aniline of mifepristone can provide compounds with altered pharmacokinetic and pharmacodynamic (PK/PD) profiles that may find use for new indications. The development of new steroid intermediates and specialized library synthesis methods were required to enable the efficient preparation of structurally complex C-11 modified mifepristone analogs.

Keywords

Library synthesis Mifepristone Parallel synthesis Steroids 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cadepond F, Ulmann A, Baulieu E-E (1997) RU486 (Mifepristone): mechanisms of action and clinical uses. Annu Rev Med 48:129–156CrossRefGoogle Scholar
  2. 2.
    von Geldern T, Tu N, Kym P, Link J, Jae H, Lai C, Apelqvist T, Rhonnstad P, Hagberg L, Koehler K, Grynfarb M, Goos-Nilsson A, Sandberg J, Österlund M, Barkem T, Höglund M, Wang J, Fung S, Wilcox D, Nguyen P, Jakob C, Hutchins C, Färnegårdh M, Kauppi B, Öhman L, Jacobson P (2004) Liver-Selective glucocorticoid antagonists: a novel treatment for type 2 diabetes. J Med Chem 47:4213–4230CrossRefGoogle Scholar
  3. 3.
    Kauppi B, Jakob C, Färnegårdh M, Yang J, Ahola H, Alarcon M, Calles K, Engström O, Harlan J, Munchmore S, Ramqvist A-K, Thorell S, Öhman L, Greer J, Gustafsson J, Carlstedt-Duke J, Carlquist M (2003) The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. J Biol Chem 278:22748–22754CrossRefGoogle Scholar
  4. 4.
    Kawai S, Nieman LK, Brandon DD, Udelsman R, Loriaux DL, Chrousos GP (1987) Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid RU 486 in man. J Pharm Exper Thera 241:401–406Google Scholar
  5. 5.
    Maltais R, Tremblay MR, Ciobanu LC, Poirier D (2004) Steroids and Combinatorial Chemistry. J Comb Chem 6:443–456CrossRefGoogle Scholar
  6. 6.
    Zuckermann RN, Kerr JM, Kent SBH, Moos WH (1992) Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis. J Am Chem Soc 114:10646–10647CrossRefGoogle Scholar
  7. 7.
    Belanger A, Philibert D, Teutsch G (1981) Regio and stereospecific synthesis of 11β-substituted 19-norsteroids. Influence of 11β-substitution on progesterone receptor affinity-(1). Steroids 37:361–382CrossRefGoogle Scholar
  8. 8.
    von Geldern TW, Link JT, Tu N, Kym PR, Lai C, Richards SJ, Jacobson PB, Bishop RD, Gates BD Preparation of cholic acid derivatives for therapeutic use as glucocorticoid receptor ligands for the treatment of metabolic disorders., WO 04/000869Google Scholar

Copyright information

© Springer Science+Business Media, Inc. 2007

Authors and Affiliations

  1. 1.Metabolic Disease Research, Global Pharmaceutical Research and DevelopmentAbbott LaboratoriesAbbott ParkUSA

Personalised recommendations